Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT06217783
Status
Recruiting

Conditions

  • Oncologic Complications and Emergencies

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Introcan Safety IV Catheter — DEVICE
    Given by IV

Study Details

To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.

Key Dates

Start date
Mar 27, 2024
Status verified
Dec 2025
Primary completion
Dec 1, 2027
Completion
Dec 1, 2027

Study Design

Enrollment
400 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Group A
    Participants will receive a catheter that is up to 1.75 inches long based on what the nurse thinks is best for you.
  • Experimental: Group B
    Participants will receive a catheter that is either 1.75 or 2.5 inches long based on what the nurse thinks is best for you.

Primary Outcome Measure

Safety and adverse events (AEs) [ Time Frame: Through study completion; an average of 1 year. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Jonathan Rowland, MD
832-450-8954
Jonathan Rowland, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX